Literature DB >> 15254301

Scabies: more than just an irritation.

J S McCarthy1, D J Kemp, S F Walton, B J Currie.   

Abstract

Human scabies, caused by skin infestation with the arthropod mite, Sarcoptes scabiei, typically results in a papular, intensely pruritic eruption involving the interdigital spaces, and flexure creases. Recent research has led to a reassessment of the morbidity attributable to this parasite in endemic communities, particularly resulting from secondary skin sepsis and postinfective complications including glomerulonephritis. This has led to studies of the benefits of community based control programmes, and to concerns regarding the emergence of drug resistance when such strategies are employed. The renewed research interest into the biology of this infection has resulted in the application of molecular tools. This has established that canine and human scabies populations are genetically distinct, a finding with major implications for the formulation of public health control policies. Further research is needed to increase understanding of drug resistance, and to identify new drug targets and potential vaccine candidates.

Entities:  

Mesh:

Year:  2004        PMID: 15254301      PMCID: PMC1743057          DOI: 10.1136/pgmj.2003.014563

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  46 in total

1.  Oral ivermectin in the treatment of scabies.

Authors:  M Elmogy; H Fayed; H Marzok; A Rashad
Journal:  Int J Dermatol       Date:  1999-12       Impact factor: 2.736

2.  Community control of scabies: a model based on use of permethrin cream.

Authors:  D Taplin; S L Porcelain; T L Meinking; R L Athey; J A Chen; P M Castillero; R Sanchez
Journal:  Lancet       Date:  1991-04-27       Impact factor: 79.321

3.  Deaths associated with ivermectin for scabies.

Authors:  R Reintjes; C Hoek
Journal:  Lancet       Date:  1997-07-19       Impact factor: 79.321

4.  Success of a scabies control program in an Australian aboriginal community.

Authors:  J R Carapetis; C Connors; D Yarmirr; V Krause; B J Currie
Journal:  Pediatr Infect Dis J       Date:  1997-05       Impact factor: 2.129

5.  Deaths associated with ivermectin treatment of scabies.

Authors:  R Barkwell; S Shields
Journal:  Lancet       Date:  1997-04-19       Impact factor: 79.321

6.  Lindane neurotoxic reaction in nonbullous congenital ichthyosiform erythroderma.

Authors:  S J Friedman
Journal:  Arch Dermatol       Date:  1987-08

7.  Ivermectin and crusted (Norwegian) scabies.

Authors:  B J Currie; G P Maguire; Y K Wood
Journal:  Med J Aust       Date:  1995-11-20       Impact factor: 7.738

8.  Acute glomerulonephritis due to skin disease, with special reference to scabies.

Authors:  C Hersch
Journal:  S Afr Med J       Date:  1967-01-14

9.  Resistance and immune response in scabies-infested hosts immunized with Dermatophagoides mites.

Authors:  L G Arlian; C M Rapp; M S Morgan
Journal:  Am J Trop Med Hyg       Date:  1995-06       Impact factor: 2.345

10.  [Obstinate pancytopenia due to lindane (gamma isomer of hexachlorocyclohexane)].

Authors:  C ALBAHARY; J DUBRISAY
Journal:  Arch Mal Prof       Date:  1957 Nov-Dec
View more
  44 in total

Review 1.  Scabies: diagnosis and treatment.

Authors:  Graham Johnston; Mike Sladden
Journal:  BMJ       Date:  2005-09-17

Review 2.  More common skin infections in children.

Authors:  Michael J Sladden; Graham A Johnston
Journal:  BMJ       Date:  2005-05-21

Review 3.  Epidermal parasitic skin diseases: a neglected category of poverty-associated plagues.

Authors:  Hermann Feldmeier; Jorg Heukelbach
Journal:  Bull World Health Organ       Date:  2009-02       Impact factor: 9.408

4.  Development of Conventional and Real-Time Quantitative PCR Assays for Diagnosis and Monitoring of Scabies.

Authors:  Samson S Y Wong; Rosana W S Poon; Sandy Chau; Sally C Y Wong; Kelvin K W To; Vincent C C Cheng; Kitty S C Fung; K Y Yuen
Journal:  J Clin Microbiol       Date:  2015-04-22       Impact factor: 5.948

5.  A Study of Clinical Profile and Quality of Life in Patients with Scabies at a Rural Tertiary Care Centre.

Authors:  Pragya Ashok Nair; Rita Vipul Vora; Nidhi B Jivani; Shailee S Gandhi
Journal:  J Clin Diagn Res       Date:  2016-10-01

6.  Treatment of Sarcoptic mange infestation in rabbits with long acting injectable ivermectin.

Authors:  Khan Sharun; Satheesh Anjana; Syed Aboobacker Sidhique; Shaji Panikkassery
Journal:  J Parasit Dis       Date:  2019-06-22

7.  A scabies outbreak in a diabetic and collagen disease ward: Management and prevention.

Authors:  Kenta Furuya; Hitoshi Nakajima; Yousuke Sasaki; Akira Ishiko; Yoshihisa Urita
Journal:  Exp Ther Med       Date:  2016-10-27       Impact factor: 2.447

8.  Diagnosis, prevention, and treatment of scabies.

Authors:  Luis Shimose; L Silvia Munoz-Price
Journal:  Curr Infect Dis Rep       Date:  2013-10       Impact factor: 3.725

9.  Comparison of safety, efficacy, and cost effectiveness of benzyl benzoate, permethrin, and ivermectin in patients of scabies.

Authors:  Narendra P Bachewar; Vijay R Thawani; Smita N Mali; Kunda J Gharpure; Vaishali P Shingade; Ganesh N Dakhale
Journal:  Indian J Pharmacol       Date:  2009-02       Impact factor: 1.200

10.  Immune response induced by candidate Sarcoptes scabiei var. cuniculi DNA vaccine encoding paramyosin in mice.

Authors:  Xiaobin Gu; Yue Xie; Shuxian Wang; Xuerong Peng; Songjia Lai; Guangyou Yang
Journal:  Exp Appl Acarol       Date:  2014-04-13       Impact factor: 2.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.